[1] TAO Na, AN Yongwei, OUYANG Shuigen et al. Dosimetric study on 3D-printing multi-channel applicator interstitial brachytherapy for cervical cancer[J]. Journal of Radiation Research and Radiation Processing, 38, 040302(2020).

[2] Hyer D E, Sheybani A, Jacobson G M et al. The dosimetric impact of heterogeneity corrections in high-dose-rate 192Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans[J]. Brachytherapy, 11, 515-520(2012).

[3] Stromberg J S, Martinez A A, Horwitz E M et al. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment[J]. Cancer Journal from Scientific American, 3, 346-352(1997).

[4] Nath R, Anderson L L, Luxton G et al. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No.43. American Association of Physicists in Medicine[J]. Medical Physics, 22, 209-234(1995).

[5] Rivard M J, Coursey B M, DeWerd L A et al. Update of AAPM task group No.43 report: a revised AAPM protocol for brachytherapy dose calculations[J]. Medical Physics, 31, 633-674(2004).

[6] CAI Guoxin, WANG Xuetao, YANG Geng et al. Monte Carlo simulation and experimental measurement of X-ray fields' dose distribution for medical accelerator[J]. Journal of Radiation Research and Radiation Processing, 33, 020202(2015).

[7] LI Lei, ZENG Fansong, WU Xiaoli et al. A GEANT4 study for the dose rate distributions of a 60Co γ-rays irradiation facility[J]. Journal of Radiation Research and Radiation Processing, 31, 020501(2013).

[8] WU Xiaowei, CUI Xiangli, LIU Zicheng et al. Dosimetric characteristics study on the Ir-192 high dose rate by Monte Carlo simulation[J]. China Medical Devices, 37, 6-9(2022).

[9] Detwiler R S, McConn R J, Grimes T F et al[R]. Compendium of material composition data for radiation transport modeling(2021).

[10] McConn R J, Gesh C J, Pagh R T et al[R]. Compendium of material composition data for radiation transport modeling(2011).

[11] Berlizov A N. MCNP-CP: a correlated particle radiation source extension of a general purpose Monte Carlo N-particle transport code[M]. ACS Symposium Series, 183-194(2006).

[12] Borg J, Rogers D W O. Monte Carlo calculations of photon spectra in air from 192Ir sources[DB/OL]. https://www.researchgate.net/publication/44064373_Monte_Carlo_calculations_of_photon_spectra_in_air_from_192-Ir_sources

[13] Ballester F, Hernández C, Pérez-Calatayud J et al. Monte Carlo calculation of dose rate distributions around wires[J]. Medical Physics, 24, 1221-1228(1997).

[14] Taylor R E P, Yegin G, Rogers D W O. Benchmarking BrachyDose: Voxel based EGSnrc Monte Carlo calculations of TG-43 dosimetry parameters[J]. Medical Physics, 34, 445-457(2007).

[15] Taylor R E P, Rogers D W O. EGSnrc Monte Carlo calculated dosimetry parameters for 192Ir and 169Yb brachytherapy sources[J]. Medical Physics, 35, 4933-4944(2008).

[16] WU Ailin, WU Aidong, ZHU Lei et al. Monte Carlo simulation study of dosimetric parameters of Varian HDR 192Ir source[J]. Chinese Journal of Radiological Medicine and Protection, 38, 859-864(2018).

[17] Pérez-Calatayud J, Ballester F, Das R K et al. Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: Report of the AAPM and ESTRO[J]. Medical Physics, 39, 2904-2929(2012).

[18] Taylor R E P, Rogers D W O. An EGSnrc Monte Carlo-calculated database of TG-43 parameters[J]. Medical Physics, 35, 4228-4241(2008).

[19] Granero D, Pérez-Calatayud J, Ballester F. Monte Carlo calculation of the TG-43 dosimetric parameters of a new BEBIG Ir-192 HDR source[J]. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 76, 79-85(2005).

[20] Lliso F, Pérez-Calatayud J, Carmona V et al. Fitted dosimetric parameters of high dose-rate sources according to the AAPM TG43 formalism[J]. Medical Physics, 28, 654-660(2001).